David Ryan - Ovation Science Head Director
| OVATF Stock | USD 0.01 0.02 64.81% |
Insider
David Ryan is Head Director of Ovation Science
| Age | 56 |
| Phone | 604 283 0903 |
| Web | https://ovationscience.com |
David Ryan Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Ryan against Ovation Science pink sheet is an integral part of due diligence when investing in Ovation Science. David Ryan insider activity provides valuable insight into whether Ovation Science is net buyers or sellers over its current business cycle. Note, Ovation Science insiders must abide by specific rules, including filing SEC forms every time they buy or sell Ovation Science'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Ryan over six months ago Disposition of 370 shares by David Ryan of Affiliated Managers subject to Rule 16b-3 |
Ovation Science Management Efficiency
The company has return on total asset (ROA) of (0.7361) % which means that it has lost $0.7361 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.884) %, meaning that it generated substantial loss on money invested by shareholders. Ovation Science's management efficiency ratios could be used to measure how well Ovation Science manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Nilyum Jhala | Trulieve Cannabis Corp | N/A | |
| CPA CPA | Intracellular Th | 68 | |
| Dina Rollman | Green Thumb Industries | 50 | |
| Robert Kremer | Trulieve Cannabis Corp | N/A | |
| Victoria Walker | Trulieve Cannabis Corp | 38 | |
| JD III | Trulieve Cannabis Corp | 54 | |
| Matthew Darin | Curaleaf Holdings | N/A | |
| Marc MD | Rockwell Medical | 63 | |
| Kimberly Rivers | Trulieve Cannabis Corp | 45 | |
| Edward Kremer | Curaleaf Holdings | 51 | |
| Steven White | Trulieve Cannabis Corp | 49 | |
| Alex CPA | Trulieve Cannabis Corp | 48 | |
| James Shorris | Curaleaf Holdings | 61 | |
| Joe Holland | Curaleaf Holdings | N/A | |
| Camilo Lyon | Curaleaf Holdings | N/A | |
| Mark Baldyga | Biofrontera | N/A | |
| Ariella Raban | Kamada | 48 | |
| Albert Bolles | Lifecore Biomedical | 66 | |
| Eran Nir | Kamada | 51 | |
| Linda Marsicano | Green Thumb Industries | 55 | |
| Yifat Esq | Kamada | 47 | |
Management Performance
| Return On Equity | -1.88 | |||
| Return On Asset | -0.74 |
Ovation Science Leadership Team
Elected by the shareholders, the Ovation Science's board of directors comprises two types of representatives: Ovation Science inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ovation. The board's role is to monitor Ovation Science's management team and ensure that shareholders' interests are well served. Ovation Science's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ovation Science's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BCom ACA, S CFO | ||
| David Ryan, Head Director | ||
| Terry Howlett, CEO Pres | ||
| Doreen McMorran, COO VP |
Ovation Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ovation Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.88 | |||
| Return On Asset | -0.74 | |||
| Operating Margin | (11.43) % | |||
| Current Valuation | 537.31 K | |||
| Shares Outstanding | 29.37 M | |||
| Shares Owned By Insiders | 28.64 % | |||
| Price To Book | 10.86 X | |||
| Price To Sales | 4.87 X | |||
| Revenue | 224.95 K | |||
| Gross Profit | 520.79 K |
Currently Active Assets on Macroaxis
Other Information on Investing in Ovation Pink Sheet
Ovation Science financial ratios help investors to determine whether Ovation Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ovation with respect to the benefits of owning Ovation Science security.